117 related articles for article (PubMed ID: 18457732)
1. [Neutropenia and thrombocytopenia in a patient presenting psoriasis treated with etanercept].
Lahbabi I; Adamski H; Le Jean S; Cannieux V; Polard E; Chevrant-Breton J
Ann Dermatol Venereol; 2008 May; 135(5):409-10. PubMed ID: 18457732
[No Abstract] [Full Text] [Related]
2. Transient and reversible thrombocytopenia in a psoriatic patient treated with etanercept.
Balato N; Gallo L; Gaudiello F; Chiurazzi F; Ayala F
J Dermatolog Treat; 2010 Mar; 21(2):117-8. PubMed ID: 19634045
[No Abstract] [Full Text] [Related]
3. Suspected rapid-onset neutropenia following etanercept use: disproved following rechallenge and lessons to be learned.
Sachdev A; Shwayder T
Int J Dermatol; 2013 Oct; 52(10):1287-8. PubMed ID: 22417135
[No Abstract] [Full Text] [Related]
4. Tinea versicolor associated with etanercept therapy.
Levy MS; Polsky D; Davidson A; Strober BE
J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S99-100. PubMed ID: 18489062
[No Abstract] [Full Text] [Related]
5. Acute myelogenous leukemia in a patient receiving etanercept for psoriasis.
Bachmeyer C; Thiolière B; Khosrotehrani K; Cattan E
J Am Acad Dermatol; 2007 Jan; 56(1):169-70. PubMed ID: 17190640
[No Abstract] [Full Text] [Related]
6. Disseminated superficial porokeratosis secondary to immunosuppression induced by etanercept for extensive psoriasis.
Stewart L; Howat A; Coulson I
Arch Dermatol; 2010 Oct; 146(10):1193-4. PubMed ID: 20956674
[No Abstract] [Full Text] [Related]
7. Etanercept-induced lichenoid reaction pattern in psoriasis.
Bovenschen HJ; Kop EN; Van De Kerkhof PC; Seyger MM
J Dermatolog Treat; 2006; 17(6):381-3. PubMed ID: 17853314
[TBL] [Abstract][Full Text] [Related]
8. The rapid onset of multiple squamous cell carcinomas during etanercept treatment for psoriasis.
Ly L; Czarnecki D
Br J Dermatol; 2007 Nov; 157(5):1076-8. PubMed ID: 17854370
[No Abstract] [Full Text] [Related]
9. Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience.
Antoniou C; Dessinioti C; Stratigos A; Avgerinou G; Stavropoulos P; Katsambas A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):979-82. PubMed ID: 19470056
[No Abstract] [Full Text] [Related]
10. Etanercept and infections.
Bertouch J
Br J Dermatol; 2009 Nov; 161(5):1209-10; author reply 1210-1. PubMed ID: 19754864
[No Abstract] [Full Text] [Related]
11. [Episode of pustular psoriasis after a tuberculin test in a patient with plaque psoriasis on treatment with etanercept].
Guinovart RM; Ferrándiz C; Bielsa I; Carrascosa JM
Actas Dermosifiliogr; 2011 Dec; 102(10):828-30. PubMed ID: 21798486
[No Abstract] [Full Text] [Related]
12. Treatment of psoriasis with etanercept in a patient with a history of primary B-cell lymphoma.
Chong BF; Wong HK
Clin Exp Dermatol; 2009 Jul; 34(5):e11-3. PubMed ID: 19040508
[TBL] [Abstract][Full Text] [Related]
13. Etanercept therapy and acute myeloid leukemia.
Bachmeyer C
Am J Hematol; 2008 Apr; 83(4):345; author reply 345. PubMed ID: 18318433
[No Abstract] [Full Text] [Related]
14. Multiple lentigines arising in resolving psoriatic plaques after treatment with etanercept.
Costa LA; Belinchón I; Betlloch I; Pérez-Crespo M; Mataix J
Dermatol Online J; 2008 Jan; 14(1):11. PubMed ID: 18319028
[TBL] [Abstract][Full Text] [Related]
15. Subgroup analyses of etanercept in pediatric patients with psoriasis.
Paller AS; Eichenfield LF; Langley RG; Leonardi CL; Siegfried EC; Creamer K; Kricorian G
J Am Acad Dermatol; 2010 Aug; 63(2):e38-41. PubMed ID: 20633781
[No Abstract] [Full Text] [Related]
16. Lichen planopilaris noted during etanercept therapy in a child with severe psoriasis.
Abbasi NR; Orlow SJ
Pediatr Dermatol; 2009; 26(1):118. PubMed ID: 19250435
[TBL] [Abstract][Full Text] [Related]
17. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
[TBL] [Abstract][Full Text] [Related]
18. Etanercept combined with methotrexate for high-need psoriasis.
Driessen RJ; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
[TBL] [Abstract][Full Text] [Related]
19. Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis.
Yamauchi PS; Lowe NJ
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S135-8. PubMed ID: 16488328
[No Abstract] [Full Text] [Related]
20. Recurrent varicella in an adult psoriasis patient treated with etanercept.
Becart S; Segaert S
Dermatology; 2008; 217(3):260-1. PubMed ID: 18667825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
